Larson Financial Group’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43K Sell
98
-722
-88% -$9.54K ﹤0.01% 3209
2026
Q1
$11.3K Buy
820
+731
+821% +$11K ﹤0.01% 2167
2025
Q4
$1.6K Hold
89
﹤0.01% 2827
2025
Q3
$1.65K Sell
89
-211
-70% -$3.31K ﹤0.01% 2778
2025
Q2
$4.8K Hold
300
﹤0.01% 2088
2025
Q1
$5.83K Buy
+300
New +$6.31K ﹤0.01% 1840

Other funds holding CLBT

Larson Financial Group's CLBT Position: Q2 2026 in Review

Larson Financial Group reduced its Cellebrite (CLBT) stake by 88% in Q2 2026, selling an estimated $9.54K and leaving 98 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #3209.

Larson Financial Group first reported a position in CLBT in Q1 2025 and has held it in 6 quarters since. The position peaked at $11.3K in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Larson Financial Group held 98 shares of Cellebrite worth $1.43K as of Q2 2026.
  • Larson Financial Group sold 722 Cellebrite shares in Q2 2026, an estimated $9.54K.
  • Cellebrite made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3209 holding.
  • Larson Financial Group first reported a position in Cellebrite in Q1 2025 and has held it in 6 quarters since.
  • Larson Financial Group's Cellebrite position peaked at $11.3K in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.